Xiaolei Ze

Xiaolei Ze


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 November 2023 in Food Chemistry
Verified
Journal Article
Closed access
LXLei Xu
Lei Xu
JLJiahao Liao
Jiahao Liao
XLXiaoqiong Li
Xiaoqiong Li
LZLiying Zhu
Liying Zhu
XWXin Wang
Xin Wang
Jinjun LiJinjun Li
Jinjun Li

3 September 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
HLHuijing Liang
Huijing Liang
XZXiaolei Ze
Xiaolei Ze
SWSilu Wang
Silu Wang
YWYimei Wang
Yimei Wang
PRPeng chen rui
Peng chen rui
XSXi Shen
Xi Shen
Commensal microorganisms in the human gut are a good source of candidate probiotics, particularly those with immunomodulatory effects that may improve health outcomes by regulating interactions between the gut microbiome and distal organs. Previously, we used an immune-based screening strategy to select two potential probiotic strains from infant feces in China, Bifidobacterium breve 207-1 (207-1) and Lacticaseibacillus paracasei 207-27 (207-27). In this study, the in vitro immunological effects and potential in vivo general health benefits of these two strains were evaluated using Lacticaseibacillus rhamnosus GG (LGG) as the control. The results showed that 207-1 and 207-27 significantly and differentially modulated the cytokine profiles of primary splenic cells, while did not induce abnormal systemic immune responses in healthy mice. They also modulated the gut microbiota composition in a strain-dependent manner, thus decreasing Gram-negative bacteria and increasing health-promoting taxa and short-chain fatty acid levels, particularly butyric acid. Conclusively, 207-1 and 207-27 shaped a robust gut environment in healthy mice in a strain-specific manner. Their potential immunomodulatory effects and other elite properties will be further explored using animal models of disease and subsequent clinical trials. This immune-based screening strategy is promising in efficiently and economically identifying elite candidate probiotics.

9 February 2026 in npj Science of Food
Verified
Journal Article
Open access
PDF file
GMGuoqing Ma
Guoqing Ma
YLYunfeng Li
Yunfeng Li
CHChen He
Chen He
JLJunqi Li
Junqi Li
JXJiawen Xie
Jiawen Xie
Xin LiuXin Liu
Xin Liu
In this 12-week trial, 136 participants with moderately dyslipidemia were randomly assigned to receive Lactiplantibacillus plantarum (LP) or placebo. In the intention-to-treat analysis, the group-by-time interaction did not reach statistical significance. However, in per-protocol set (adherence ≥85% and no antibiotic use), LP supplementation reduced low-density lipoprotein cholesterol (LDL-C) (−0.118 mmol/L) and total cholesterol (TC) (−0.163 mmol/L), compared with the placebo (both Pgroup×time < 0.05). Post-intervention group differences were identified in gut microbial genera and species, correlated with changes in bile acids, which in turn were jointly related to lipid reduction. Microbiota-based machine learning models well-predicted the lipid reductions. Subjects with lower genetic risk scores experienced large decreases in LDL-C (Mean ± SD: −0.749 ± 0.632 mmol/L) and TC (−1.306 ± 0.436 mmol/L) (both Ptrend and Pinteraction < 0.001). Our data supported the beneficial effects of LP in patients with moderate dyslipidemia involving gut microbiota and host genetics.

1 January 2026 in Bioscience of Microbiota, Food and Health
Verified
Journal Article
Open access
PDF file
LHLi Huang
Li Huang
YZYunqin Zheng
Yunqin Zheng
QLQianfeng Liu
Qianfeng Liu
YFYiran Feng
Yiran Feng
ZMZewei Ma
Zewei Ma
MZMeilin Zhang
Meilin Zhang
Depression is one of the common psychiatric disorders, and it has been reported that the imbalance in the microbiota-gut-brain (MGB) axis contributes to the pathogenesis of depression. Milk fat globule membrane (MFGM) can impact the gut-brain axis by regulating the intestinal flora and metabolite production. The aim of this study was to investigate whether MFGM could ameliorate depressive-like behaviors induced by chronic unpredictable mild stress (CUMS) and further elucidate the potential mechanism through a fecal microbiota transplantation (FMT) experiment. Male Sprague-Dawley rats were provided with an MFGM diet for 5 weeks after the induction with CUMS. Depressive-like behaviors were assessed, and the levels of neurotransmitters, neuroendocrine hormones, microbiota, short-chain fatty acids (SCFAs), and tight junction proteins, including occludin and zonula occludens-1 (ZO-1), were measured. It was revealed that MFGM could alleviate the depressive-like behaviors in CUMS rats. MFGM up-regulated the expression of occludin and ZO-1 and ameliorated intestine pathological changes in CUMS rats. Moreover, MFGM increased the levels of 5-hydroxytryptamine (5-HT), dopamine (DA), and norepinephrine and decreased the levels of neuroendocrine hormones in CUMS rats. Furthermore, it was confirmed that the concentrations of SCFAs, DA, 5-HT, and tight junction proteins significantly increased in the recipient rats that were inoculated with the fecal microbiota from the rats after MFGM treatment. These findings demonstrated that MFGM could alleviate depressive-like behaviors in CUMS rats and was possibly associated with modulation of the gut microbiota and up-regulation of SCFAs and monoamine neurotransmitters.